Potential Limitations of a Very Short Course of Antimicrobial Therapy for Ventilator-Associated Pneumonia

To the Editor—We read with great interest the study by Klompas et al suggesting that a very short course of antimicrobial therapy (1–3 days) might not be associated with a higher risk of ventilator or hospital death in patients with suspected ventilator-associated pneumonia (VAP), compared with a longer course [1]. We discuss some potential limitations of the study.

http://ift.tt/2sgVbVI